Insider Transactions in Q2 2024 at Zentalis Pharmaceuticals, Inc. (ZNTL)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 21
2024
|
Enoch Kariuki Director |
BUY
Grant, award, or other acquisition
|
Direct |
41,581
+34.27%
|
-
|
|
Jun 21
2024
|
Jan Skvarka Director |
BUY
Grant, award, or other acquisition
|
Direct |
41,581
+31.71%
|
-
|
|
Jun 21
2024
|
David Michael Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
48,429
+20.07%
|
-
|
|
May 31
2024
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
9,597
-1.49%
|
$105,567
$11.98 P/Share
|
|
May 24
2024
|
Luke Nathaniel Walker Director |
BUY
Grant, award, or other acquisition
|
Direct |
72,481
+50.0%
|
-
|
|
May 09
2024
|
Diana Hausman Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,356
-0.89%
|
$40,272
$12.62 P/Share
|